SAN DIEGO, June 28, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis
Last week, Medical Marijuana, Inc. announced its partnership with Canadian cannabis company Salvation Botanicals and Smith will now serve as the liaison for this partnership.
"I'm excited to help spearhead the future of Medical Marijuana, Inc.'s presence in Canada with this new position," said Smith. "I've been working closely with our Canadian partners to come up with many out-of-the-box ideas to meet the increased demand for high-quality products in Canada."
Smith, who is the owner of an ethically-sourced hemp clothing and accessory company called Hempy's, is a Harvard Business School graduate and has held executive positions in a variety of different industries throughout the U.S. Now, Smith is bringing his expertise to Medical Marijuana, Inc. as they continue to break ground in the Canadian cannabis market. Smith will be leading efforts to increase the availability of reliable cannabis products in Canada.
"We've been longtime friends with Kenneth and his company and believe that he has the business skills to help our company succeed in this quickly-expanding market," said Medical Marijuana Inc. CEO Dr. Stuart Titus. "I have always admired his forward-thinking entrepreneurship and I believe that he shares the same passion for cannabis and hemp that our company does."
Medical Marijuana, Inc. produces industry-leading CBD brands including Real Scientific Hemp Oil™ (RSHO™), Dixie Botanicals® and Cannabis Beauty Defined® in the United States for distribution internationally. With its new partnership with Salvation Botanicals, Medical Marijuana, Inc. will soon be offering its products, and a number of new products, in Canada.
"Salvation Botanicals is honored to be chosen to help facilitate Medical Marijuana's expansion into the Canadian market, and we look forward to the opportunity to work with Kenneth on this exciting project," said Salvation Botanicals Founder and CEO Cliff Wiltshire. "We believe that by combining Medical Marijuana's pioneering pedigree with Salvation's dedication to manufacturing the highest quality products and standard-setting analytical testing, we will make a significant impact on the Canadian market."
Smith is joining Medical Marijuana Inc. at a pivotal time for cannabis in Canada. The country recently legalized recreational marijuana use for adults, which is expected to benefit both the medical and recreational cannabis business sectors. Retail sales of recreational cannabis officially start on October 17, 2018.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.
About Salvation Botanicals, Ltd.
Salvation Botanicals is a private company based in Vancouver Island, British Columbia, that is dedicated to the testing and production of high quality standardized cannabinoid products for the international cannabis market. Salvation operates one of the first analytics laboratories in Canada, accredited by Health Canada to test cannabis and derivatives.
Salvation Botanicals holds a Dealer's License under the Controlled Substances Act, with authority to extract and produce oil within Health Canada guidelines. In 2016 Health Canada granted Salvation a Hemp Processing License (HPL) permitting production and sale and export of seed & grain and its derivatives.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to: the terms and conditions of the proposed transaction; the terms and conditions of the proposed private placement; use of funds; and the business and operations of the Company after the proposed change of business. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the uncertainties surrounding the cannabis industry in North America. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Salvation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT:Public Relations Contact:Andrew HardChief Executive Officer CMW MediaP. 858-264-6600 email@example.com www.cmwmedia.com
View original content:http://www.prnewswire.com/news-releases/medical-marijuana-inc-appoints-new-director-of-canadian-operations-300673791.html
SOURCE Medical Marijuana, Inc.
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All